Get startedLog in
    Picture of Organon & Co logo

    OGN — Organon & Co Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Organon & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    C2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line2,2561,3519171,023864
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items-62498199180225
    Discontinued Operations
    Unusual Items
    Purchased R&D
    Other Non-Cash Items
    Changes in Working Capital-117702-452-155-267
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities2,1872,458858799939
    Capital Expenditures-255-296-427-261-351
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-3-18571-162
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Other Investing Cash Flow
    Cash from Investing Activities-258-481-420-260-513
    Financing Cash Flow Items-3,687-8,916-35-17-22
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-2,175-1,333-433-569-368
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-249667-31-13-18